ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Timber Pharmaceuticals Inc

Timber Pharmaceuticals Inc (TMBR)

0.3426
0.00
(0.00%)
Closed December 06 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.3426
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.3426
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TMBR Latest News

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and...

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to be Acquired by LEO Pharma

Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to...

Timber Pharmaceuticals Discloses Communication From NYSE American

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for...

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber...

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

- Timber has now Enrolled Over 60% of Patients for Pivotal TMB-001 Phase 3 ASCEND Clinical Trial - WARREN, NJ, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc...

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI - - Timber has enrolled...

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the subtype of congenital ichthyosis - BASKING...

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

Company Progressing With Pivotal Phase 3 ASCEND Clinical Trial in the U.S., Canada, Italy, France, and Germany BASKING RIDGE, NJ, Feb. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UAMYUnited States Antimony Corp
$ 1.895
(40.37%)
20.09M
GPUSHyperscale Data Inc
$ 6.79
(36.35%)
643k
CHROChannel Therapeutics Corporation
$ 0.8349
(26.31%)
1.09M
ROLRHigh Roller Technologies Inc
$ 6.60
(16.40%)
29.62k
DSSDSS Inc
$ 1.04
(12.95%)
82.5k
CTMCastellum Inc
$ 0.28675
(-18.07%)
6.42M
PWPower REIT
$ 1.90
(-16.30%)
981.54k
UMACUnusual Machines Inc
$ 8.66
(-15.51%)
4.14M
UAVSAgEagle Aerial Systems Inc
$ 5.735
(-14.40%)
1.81M
SCPXScorpius Holdings Inc
$ 0.3978
(-13.75%)
515.68k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
$ 0.9556
(-4.11%)
613M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 29.61
(1.68%)
48.51M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 3.165
(3.77%)
39.88M
TZADirexion Daily Small Cap Bear 3X Share New
$ 10.485
(-1.08%)
30.38M
SPYSPDR S&P 500
$ 607.81
(0.19%)
30.29M

Discussion

View Full Feed
biotechinvestor1 biotechinvestor1 2 minutes ago
For the true halo investors on this board: I hope you are getting the same sense of confidence as I am when you see how the bears have to resort to silly arguments to explain their position. Just in the past 24 hours we have read about Martial Law and deravatives causing alteogen's 33% drop, company
HALO
StockInfo11 StockInfo11 3 minutes ago
CEO Mark Fedosiewich presents the investment case for gold junior VIO.v, highlighting upcoming assay results from the ongoing 60,000m drill program at VIO's flagship Belleterre Gold Project in Quebec, which historically produced over 750,000 oz of gold at 10.7 g/t.
https://youtu.be/DTYdwI3C9
VIO
delerious1 delerious1 4 minutes ago
Hope so....has to beat .392 for 1 year high.....$0.5692 Sep 15, 2021 all time high
HBARUSD
varmit varmit 4 minutes ago
Howdy layton 
I aint got squat from these idiots !!!!!
Some day someones gonna mine bouse and were gettin psod what we are owed
Golden Cross Golden Cross 4 minutes ago
$ILLR Triller Could Have META-Like Move In It!

META/Facebook Went From $38 2012 IPO Price to a high of $595! Early doubters saw shares drop below $18, but look at it now! 💥

Believe in your vision. The journey might be rough, but persistence pays off! 💪&
ILLR
Kimbrown Kimbrown 4 minutes ago
FnF relist price should be $25-35 considering Warrants execution and Preferred conversion to Commons
FNMA
Kimbrown Kimbrown 4 minutes ago
FnF relist price should be $25-35 considering Warrants execution and Preferred conversion to Commons
FNMA
threewheeler threewheeler 5 minutes ago
thankx for keeping us in loop up to the point u can, the biggest problem I see is just OTC Markets not reflecting any of the filings they should have, someone really needs to get on that, in the mean time I'm adding what I can here about 12K more today
AZRH
GetSeriousOK GetSeriousOK 5 minutes ago
Why do you want a post number? I'll say it again and you can frame it.

1) BIEL is DEFINITELY NOT A SCAM.

2) BIEL is VERY CLOSE TO PROFITABILITY.

regarding #1: of course it's not a scam. Nobody seriously thinks this company is a scam. Do you know what a sc
BIEL
Hercules1 Hercules1 5 minutes ago
welcome blundering idiot.
HMBL
dinogreeves dinogreeves 6 minutes ago
I too have shares and calls. Good luck to you, as if you need any luck on SMCI.
SMCI
pos_stock_hoarder pos_stock_hoarder 7 minutes ago
They were a top notch band! Here's live.

https://youtu.be/9IVojgL2zmQ
titan11 titan11 7 minutes ago
 Is that a typo? Did you mean "exposing yourself" lol
StockInfo11 StockInfo11 7 minutes ago
On the TokStocks Podcast, BOGO.v CEO Kelly Malcolm highlighted their fully permitted Nevada gold mine, which delivered $1M USD in revenue from initial production during FY2024.
https://youtu.be/wt26qMFYNyY
BOGO is advancing toward 2025 full-scale production while exploring sulfide mine
BOGO
Tesla thru the roof Tesla thru the roof 7 minutes ago
Wow amazing after-hours action. TSLA THE JUGGERNAUT heads to all time high
TSLA
al44 al44 8 minutes ago
For one of their criminal heroes-

Disgusting still
https://media.gettr.com/group4/getter/2024/12/06/22/d49dbb6c-3098-5d86-3765-224e5c334bac/5b4864d5da945e1fcd201c1756505ebb_768x0.png
Zorax Zorax 8 minutes ago
Look at that congressbitch's eyes. If it's not photoshopped, almost totally dilated in bright light. She's doped up.
biotecholdguy biotecholdguy 8 minutes ago
Which do you want in your body at this time? Altogen's testing is about 15 years behind FDA proven HALO. Why doesn't Alteogen need testing? Because they've copied HALO? (Merek knows!)
HALO
Jetmek_03052 Jetmek_03052 8 minutes ago
Yes this is TRUE!

Oh~? So Poo28's posts aren't true and your posts are~?

Poo just stated that the upgrade to the QB level would happen "once DBMM reached $.01 for thirty days and maintained it".

That is categorially UNTRUE. Anyone can see that DBMM DOES
DBMM
starboy starboy 10 minutes ago
"Maybe" The Chantels. January 1958. One of the greatest songs of the '50's.
And one of the most stirring voices of the era. (Arlene Smith, lead) . https://www.youtube.com/watch?v=IePTH1PWzAs
https://en.wikipedia.org/wiki/The_Chantels
titan11 titan11 10 minutes ago
He is some piece of work that's for sure! My 1st Dwyer experience was BCAP made bank! Man that's like a lifetime ago! Have a great weekend fine sir! Appreciate you!
BCAP
biotechinvestor1 biotechinvestor1 10 minutes ago
Alteogen has many other profitable products. The fact that it's market cap is larger than halozyme has nothing to do with the patent issue or even with hyaluronidases.

I have a feeling you already knew this.


HALO
FACT-MASTER FACT-MASTER 10 minutes ago
FDA Approval of TSC-100 / TSC-101 possible next week, imo.

Has fact-master gone crazy?,.. you may ask.

Well no, it's really quite logical. What best practice has TScan developed to address safety?

https://www.tscan.com/technology/safetyscan/
TCRX

Your Recent History

Delayed Upgrade Clock